skip to main content

RISK OF PRECANCEROUS CERVICAL LESIONS A DESCRIPTIVE STUDY AT SAPURAN HEALTH CENTER, WONOSOBO CITY

*Dinta Ayuda Farras orcid  -  Epidemiology Department, Faculty of Public Health, Diponegoro University, Indonesia
Lintang Dian Saraswati  -  Epidemiology Department, Faculty of Public Health, Diponegoro University, Indonesia
Praba Ginandjar  -  Epidemiology Department, Faculty of Public Health, Diponegoro University, Indonesia
Arie Wuryanto  -  Epidemiology Department, Faculty of Public Health, Diponegoro University, Indonesia
Open Access Copyright (c) 2020 Journal of Public Health for Tropical and Coastal Region

Citation Format:
Abstract

Cervical cancer is a disease that attacks women caused by Human Paplilloma Virus. Early sign of this cancer is discovery precancerous cervical lesions. Early prevention of knowing the presence of these lesionss is by early detection of the Visual Inspection Acetic Acid (VIA) method. This study was an observational research using case control design. Samples were taken is 126 people, 63 people as total cases and 63 peoples as control. using simple random sampling. Univariate data analyzed and presented in frequency distribution. Characteristics of respondents in this study include the majority of respondents responden were women above 35 years old (60,3%) and low education or lower than 9 years (78,6%). The results showed that 49,2%% had age of first sexual intercourse <20 years, 10,3% had number of sexual partner >1, and 58,3% respondent had ≥3 number of parity. Woman with number of parity ≥3 had precancerous cervical lesionss.

 

Fulltext View|Download
Keywords: Precancerous cervical lesionss;VIA;Cervical Cancer

Article Metrics:

  1. Markovic N, Markovic O. What every woman should know about cervical
  2. cancer. 2nd ed. USA: Springer Nature; 2016. 53–54 p
  3. Malagón T, Louvanto K, Ramanakumar A V., Koushik A, Coutlée F, Franco EL. Viral load of human papillomavirus types 16/18/31/33/45 as a redictor of cervical intraepithelial neoplasia and cancer by age. Gynecol Oncol. 2019;155(2):5–7
  4. Sankaranarayanan R, Wesley RS, WHO. A practical manual on visual
  5. screening for cervical neoplasia. Geneva: International Agency for Research on Cancer; 2003. 9–10 p
  6. IGP MM. Sensitifitas dan spesifisitas Inspeksi Visual Asam Asetat pada
  7. lesi serviks di Desa Nyambu Kediri Tabanan. E-Journal Obstet Gynecol
  8. Udayana. 2015;3:32–8
  9. Basu P, Taghavi K, Hu S-Y, Mogri S, Joshi S. Management of cervical
  10. premalignant lesionss. Curr Probl Cancer [Internet]. 2018;3–4
  11. Available from: https://doi.org/10.1016/j.currproblca
  12. ncer.2018.01.010
  13. ACCP. Delivering clinical services and strengthening linkages at
  14. planning and implementing cervical cancer prevention and control
  15. programs: a manual for managers. Alliance Cerv Cancer Prev. 2004;30
  16. Marmi. Kesehatan Reproduksi. 1st ed. Yogyakarta: Pustaka Pelajar;
  17. 270–274 p
  18. Kementerian Kesehatan Republik Indonesia. Pedoman teknis
  19. pengendalian kanker payudara dan kanker leher rahim. Jakarta; 2008
  20. Vahedpoor Z, Behrashi M, Khamehchian T, Abedzadehkalahroudi M, Moravveji A. Comparison of the diagnostic value of the visual inspection with acetic acid ( VIA ) and Pap smear in cervical cancer screening. Taiwan J
  21. Obstet Gynecol [Internet]. 2019;58(3):345–8. Available from:
  22. https://doi.org/10.1016/j.tjog.2019.03.010
  23. Sharma P, Pattanshetty SM. A study on risk factors of cervical cancer
  24. among patients attending a tertiary care hospital : A case-control study
  25. Clin Epidemiol Glob Heal [Internet]. 2017;1–5. Available from:
  26. http://dx.doi.org/10.1016/j.cegh
  27. Kurniati K. Pengaruh penggunaan kontrasepsi terhadap kejadian lesi
  28. prakanker leher rahim pada wanita yang melakukan pemeriksaan
  29. inspeksi visual dengan asam asetat (IVA) di tiga puskesmas Jakarta
  30. Timur tahun 2011. Universitas Indonesia; 2012
  31. Baray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global
  32. cancer statistics 2018 : globocan estimates of incidence and mortality
  33. worldwide for 36 cancers in 185 countries. Am Cancer Soc. 2018;68(November/Desember 2018):394–424

Last update:

No citation recorded.

Last update:

No citation recorded.